Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Apr 25;54(2):22.
doi: 10.3390/medicina54020022.

Prothrombin Complex Concentrate for Warfarin-Associated Intracranial Bleeding in Neurosurgical Patients: A Single-Center Experience

Affiliations
Free PMC article

Prothrombin Complex Concentrate for Warfarin-Associated Intracranial Bleeding in Neurosurgical Patients: A Single-Center Experience

Jomantė Mačiukaitienė et al. Medicina (Kaunas). .
Free PMC article

Abstract

Objective: The number of patients presenting with warfarin-associated intracranial bleeding and needing neurosurgical intervention is growing. Prothrombin complex concentrate (PCC) is commonly used for anti-coagulation reversal before emergent surgery. We present our experience with PCC use in patients presenting with coagulopathy and needing urgent craniotomy. Methods: We retrospectively identified all patients presenting with intracranial bleeding and coagulopathy due to warfarin use, requiring urgent neurosurgical procedures, from January, 2014 (implementation of 4-PCC therapy) until December, 2016. For coagulation reversal, all patients received 4-PCC (Octaplex) and vitamin K. Results: Thirty-five consecutive patients (17 men; median age 72 years) were administered 4-PCC before emergent neurosurgical procedures. The majority of patients presented with traumatic subdural hematoma (62%) and spontaneous intracerebral hemorrhage (32%). All patients were taking warfarin. Median international normalized ratio (INR) on admission was 2.94 (range: 1.20 to 8.60). Median 4-PCC dose was 2000 I.U. (range: 500 I.U. to 3000 I.U.). There was a statically significant decrease in INR (p < 0.01), PT (p < 0.01), and PTT (p = 0.02) after 4-PCC administration. Postoperative INR values were ≤3.00 in all patients, and seven (20%) patients had normal INR values. There were no 4-PCC related complications. Four (11%) patients developed subdural/epidural hematoma and 20 (57%) patients died. Mortality was associated with lower Glasgow coma scale (GCS) score. Conclusions: The 4-PCC facilitates INR reversal and surgery in patients presenting with warfarin-associated coagulopathy and intracranial bleeding requiring urgent neurosurgical intervention.

Keywords: intracranial hemorrhage; prothrombin complex concentrate; warfarin.

Conflict of interest statement

The authors declare no conflicts of interest.

Similar articles

See all similar articles

References

    1. Bechtel B.F., Nunez T.C., Lyon J.A., Cotton B.A., Barrett T.W. Treatments for reversing warfarin anticoagulation in patients with acute intracranial hemorrhage: A structured literature review. Int. J. Emerg. Med. 2011;4:40. doi: 10.1186/1865-1380-4-40. - DOI - PMC - PubMed
    1. Ansell J., Hirsh J., Hylek E., Jacobson A., Crowther M., Palareti G. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest. 2008;133:160S–198S. doi: 10.1378/chest.08-0670. - DOI - PubMed
    1. Jonas D.E., Bryant Shilliday B., Laundon W.R., Pignone M. Patient time requirements for anticoagulation therapy with warfarin. Med. Decis. Making. 2010;30:206–216. doi: 10.1177/0272989X09343960. - DOI - PMC - PubMed
    1. Zubkov A.Y., Mandrekar J.N., Claassen D.O., Manno E.M., Wijdicks E.F.M., Rabinstein A.A. Predictors of outcome in warfarin-related intracerebral hemorrhage. Arch. Neurol. 2008;65:1320–1325. doi: 10.1001/archneur.65.10.1320. - DOI - PubMed
    1. Huttner H.B., Schellinger P.D., Hartmann M., Köhrmann M., Juettler E., Wikner J., Mueller S., Meyding-Lamade U., Strobl R., Mansmann U., et al. Hematoma growth and outcome in treated neurocritical care patients with intracerebral hemorrhage related to oral anticoagulant therapy: Comparison of acute treatment strategies using vitamin K, fresh frozen plasma, and prothrombin complex concentrates. Stroke. 2006;37:1465–1470. doi: 10.1161/01.STR.0000221786.81354.d6. - DOI - PubMed

MeSH terms

Feedback